Cellbioengines
Founded 2022 · 5 employees on LinkedIn · 1 known investors
Find your way into Cellbioengines
1,141 people in our graph share verified history with the Cellbioengines team — schools, employers, funds. One of them is your warm intro.
Yaryna Nychunlockedknows Ajay Vishwakarma · together at Harvard University (overlapped)
×5knows the team · via Broad Institute of MIT and Harvard
×2knows the team · via Massachusetts General Hospital
×3knows the team · via Harvard University
knows the team · via Massachusetts Institute of Technology
Cell BioEngines is a clinical-stage biotech company developing allogeneic "off-the-shelf" cell therapies from "super donor" stem cells, using transgene-free scalable manufacturing and HLA-guided design. It pursues stem cell-derived therapeutics across oncology and regenerative medicine.
Founders & leadership
Cellbioengines was founded in 2022 by Ajay Vishwakarma and Alexey Bersenev.
AV
Ajay VishwakarmainFounder and CEOAjay Vishwakarma holds a DMD and MS from Harvard Medical School and MIT, and an MBA; he trained at the Broad Institute and founded Cell BioEngines, a clinical-stage biotech company developing allogeneic stem cell therapies for oncology and regenerative medicine.
AB
Alexey BersenevinCo-Founder, CTO
Investors · 1
Competitors · 3
by search overlap
Cellectis9 shared keywordsCellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.
Cellipont7 shared keywordsCellipont Bioservices is a contract development and manufacturing organization (CDMO) that provides GMP manufacturing and development services for advanced cell therapies. It serves pharma and biotech clients developing cell therapy treatments.
Cellphire7 shared keywordsCellphire Therapeutics develops platelet-based and freeze-dried cellular therapeutics for transfusion medicine, focused on controlling hemorrhage. Through its veterinary subsidiary BodeVet, it also markets freeze-dried platelet products for companion and exotic animals.
Companies competing with Cellbioengines for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cellbioengines do?
- Cell BioEngines is a clinical-stage biotech company developing allogeneic "off-the-shelf" cell therapies from "super donor" stem cells, using transgene-free scalable manufacturing and HLA-guided design. It pursues stem cell-derived therapeutics across oncology and regenerative medicine.
- Who founded Cellbioengines?
- Cellbioengines was founded by Ajay Vishwakarma, Alexey Bersenev in 2022.
- Who are Cellbioengines's investors?
- Cellbioengines's investors include The Innovation Space.